FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

SPOTLIGHT: Bill would allow FDA to improve generic biotech drugs

Tools
Tags
Brand Name
Food and Drug Administration (FDA)
Generics


Two members of Congress have introduced a bill that would allow the FDA to approve generic versions of biotechnonology drugs, though it also would allow companies making brand-name biotech drugs to keep their exclusive rights for at least 12 years before the generics could hit the market. It would also require clinical trials for the generics, though the FDA could waive that requirement. Article

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.